Capricor announces FDA acceptance, Priority Review for deramiocel BLA
Capricor Therapeutics (CAPR) announced the U.S. Food and Drug Administration has accepted for review its Biologics License Application seeking ...
Remembering the Legacy of Boston Celtics Star Reggie Lewis That Shines On Despite His ...
Reggie Lewis, a promising Boston Celtics star, tragically passed away at 27 due to hypertrophic cardiomyopathy. Despite a ...
Taiwan News6 小时
Full Year Trading Update
Pratteln, Switzerland, March 4, 2025 – Santhera Pharmaceuticals (SIX: SANN) today provides a trading update for the fiscal year 2024 and an outlook for 2025 and beyond.
Tenaya Therapeutics Announces Proposed Public Offering
Tenaya Therapeutics, Inc. (Nasdaq: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and ...
Rocket Pharmaceuticals price target raised to $52 from $51 at Scotiabank
Scotiabank raised the firm’s price target on Rocket Pharmaceuticals (RCKT) to $52 from $51 and keeps an Outperform rating on the shares. The ...
Muscular Dystrophy News22 小时
DMD and the heart
Most people with Duchenne muscular dystrophy (DMD) develop heart problems by adulthood, making management of cardiac health ...
Tenaya Therapeutics to Participate in Upcoming March Investor Conferences
Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and ...